Comparative bleeding risk between angiotensin II receptor blockers with high versus low P-glycoprotein inhibitory activity in patients with atrial fibrillation receiving direct oral anticoagulants. [PDF]
Kim S +5 more
europepmc +1 more source
Olmesartan-Induced Enteritis Mimicking Small Bowel Crohn's Disease. [PDF]
Monti G +4 more
europepmc +1 more source
Not Only Enteropathy: The Overlooked "Gastric Side" of Olmesartan. [PDF]
Pugliano CL +5 more
europepmc +1 more source
Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis. [PDF]
Alawad OM +5 more
europepmc +1 more source
Frequency and Profiles of Drug Combinations Constituting the Triple Whammy in Japan: An Analysis of a Patient Estimation Database. [PDF]
Maese M +7 more
europepmc +1 more source
Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]
Gong Z, Huang L, Long X, Zhang Y.
europepmc +1 more source
Pharmacotherapeutic Optimization in a Polymedicated Patient Through Coordinated Pharmaceutical Intervention: A Community Pharmacy Case Report. [PDF]
Vera Peña A +5 more
europepmc +1 more source
An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor Therapy. [PDF]
Lybik N +6 more
europepmc +1 more source
Olmesartan-Associated Enteropathy With Severe Diarrhoea and Acute Kidney Injury. [PDF]
Nikolaeva A, Della Vecchia A.
europepmc +1 more source
Olmesartan-associated enteropathy presenting with metabolic acidosis and acute kidney injury requiring hemodialysis: a rechallenge-confirmed case. [PDF]
Sugiura T +7 more
europepmc +1 more source

